Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts

Früh M, De Ruysscher D, Westeel V, de Marinis F, Paz Ares L, O'Brien M, Felip E, Garrido P, Novello S, Besse B, Cappuzzo F, Califano R, Blackhall F, Reck M, Panje C, Putora P. Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts. Lung Cancer 2020; 146:6-11.